Morphine-induced antinociception in the formalin test: Sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents

Behavioural Pharmacology

Volumn 18, Issue 3, 2007, Pages 177-184

  Zarrindast, Mohammad Reza ^a,b,c   Asgari Afshar, Ali ^a   Sahebgharani, Mousa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

Author keywords

Dopamine receptors; Formalin test; Morphine; Mouse; Nitric oxide; Sensitization

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ARGININE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FORMALDEHYDE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE ANTAGONIST; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; MALE; MOUSE; NONHUMAN; SENSITIZATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALGESICS, OPIOID; ANIMALS; ARGININE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FORMALDEHYDE; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PAIN MEASUREMENT; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 34247223739     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32813c5462     Document Type: Article

References (69)

1. Abbott FV, Franklin KB, Westbrook RF (1995). The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60:91-102.
2. Afanas'ev I, Ferger B, Kuschinsky K (2000). The associative type of sensitization to D-amphetamine is expressed as an NO-dependent dramatic increase in extracellular dopamine in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol 362:232-237.
3. Beninger RJ, Miller R (1998). Dopamine D1-like receptors and rewardrelated incentive learning. Neurosci Biobehav Rev 22:335-345.
4. Brignola G, Calignano A, Di Rosa M (1994). Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 113:1372-1376.
5. Cador M, Bjijou Y, Stinus L (1995). Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395.
6. Calignano A, Persico P, Mancuso F, Sorrentino L (1993a). Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur J Pharmacol 231:415-419.
7. Calignano A, Persico P, Mancuso F, Sorrentino L (1993b). L-Arginine modulates morphine-induced changes in locomotion in mice. Ann Ist Super Sanita 29:409-412.
8. Campos F, Alfonso M, Vidal L, Faro LR, Duran R (2006). Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study. Eur J Pharmacol 548:90-98.
9. Capone F, Aloisi AM (2004). Refinement of pain evaluation techniques. The formalin test. Annali dell'Istituto Superiore di Sanita 40:223-229.
10. Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA Jr (2006). Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci 26:6450-6457.
11. Dizgah IM, Karimian SM, Zarrindast MR, Sohanaki H (2005). Attenuation of morphine withdrawal signs by a D1 receptor agonist in the locus coeruleus of rats. NeuroReport 16:1683-1686.
12. Dubuisson D, Dennis SG (1997). The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4:161-174. Eur J Pharmacol 548:90-98.
13. Fricchione G, Stefano GB (2005). Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Med Sci Monit 11:MS54-MS65.
14. Fukazawa Y, Maeda T, Hamabe W, Kumamoto K, Gao Y, Yamamoto C, et al. (2005). Activation of spinal anti-analgesic system following electroacupuncture stimulation in rats. J Pharmacol Sci. 99:408-414.
15. Gaiardi M, Bartoletti A, Bacchi A, Gubellini C, Costa M, Babbini M (1991). Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats. Psychopharmacology 103: 183-190.
16. Gholami A, Haeri-Rohani A, Sahraie H, Zarrindast MR (2002). Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat. Eur J Pharmacol 449:269-277.
17. Gholami A, Zarrindast MR, Sahraei H, Haerri-Rohani A (2003). Nitric oxide within the ventral tegmental area is involved in mediating morphine reward. Eur J Pharmacol 458:119-128.
18. Goessler UR, Hein G, Sadick H, Maurer JT, Hormann K, Verse T (2005). Physiology, role and neuropharmacology of yawning. Laryngorhinootologie 84:345-351.
19. Gracy KN, Pickel VM (1997). Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res 747:259-272.
20. Haracz JL, MacDonall JS, Sircar R (1997). Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Res 746:183-189.
21. Homayoun H, Khavandgar S, Mehr SE, Namiranian K, Dehpour AR (2003). The effects of FK506 on the development and expression of morphine tolerance and dependence in mice. Behav Pharmacol 14:121-127.
22. Hyytia P, Ingman K, Soini SL, Laitinen JT, Korpi ER (1999). Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking. Naunyn Schmiedebergs Arch Pharmacol. 360:391-401.
23. Itzhak Y (1997). Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 282:521-527.
24. Jett MF, Michelson S (1996). The formalin test in rat: validation of an automated system. Pain 64:19-25.
25. Jeziorski M, White FJ (1995). Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol 275:235-244.
26. Kalinichev M, White DA, Holtzman SG (2004). Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology (Berl) 177:61-67.
27. Khoshnoodi MA, Motiei-Langroudi R, Tahsili-Fahadan P, Yahyavi-Firouz-Abadi N, Ghahremani MH, Dehpour AR (2006). Involvement of nitric oxide system in enhancement of morphine-induced conditioned place preference by agmatine in male mice. Neurosci Lett 399:234-239.
28. Kim HS, Park WK (1995). Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J Pharmacol Exp Ther 275:551-557.
29. Kimes AS, Vaupel DB, London ED. (1993). Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology (Berl) 112:521-524.
30. Kivastik T, Rutkauskaite J, Zharkovsky A (1996). Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol Biochem Behav 53:1013-1015.
31. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW (1993). Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA. 90:5162-5166.
32. Kuribara H (1995). Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 14:251-258.
33. Langroudi RM, Khoshnoodi MA, Abadi NY, Fahadan PT, Ghahremani MH, Dehpour AR (2005). Effect of cyclosporin A on morphine-induced place conditioning in mice: involvement of nitric oxide. Eur J Pharmacol 507:107-115.
34. Lattanzi R, Negri L, Schmidhammer H, Giannini E (2002). Antinociceptive activity of a novel buprenorphine analogue. Life Sci 70:2177-2185.
35. Leland NH, Barry DG (1990). Changes of substance P-like immunoreactivity in the dorsal horn are associated with the plastic behavioral response to formalin stimulus. Brain Res 537:287-292.
36. Lue WM, Su MT, Lin WB, Tao PL (1999). The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices. Eur J Pharmacol 383:129-135.
37. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Navarro M, Minarro J (2004). 7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine. Behav Brain Res 150:73-82.
38. McBride WJ, Murphy JM, Ikemoto S (1999). Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101:129-152.
39. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D (2005). Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57:217-252.
40. Narita M, Suzuki M, Imai S, Narita M, Ozaki S, Kishimoto Y, et al. (2004). Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain. Life Sci. 74:2655-2673.
41. Park K, Vora U, Darling SF, Kolta MG, Soliman KF (2001). The role of inducible nitric oxide synthase in cocaine-induced locomotor sensitization. Physiol Behav 74:441-447.
42. Perugini M, Vezina P (1994). Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690-696.
43. Portugal-Santana P, Doretto MC, Tatsuo MA, Duarte ID (2004). Involvement of prolactin, vasopressin and opioids in post-ictal antinociception induced by electroshock in rats. Brain Res 1003:1-8.
44. Pudiak CM, Bozarth MA (1993). L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 53:1517-1524.
45. Rezayof A, Amini R, Rassouli Y, Zarrindast MR (2006). Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents. Physiol Behav 88:124-131.
46. Sahraei H, Falahi M, Zarrindast MR, Sabetkasaei M, Ghoshooni H, Khalili M (2004). The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. Eur J Pharmacol 503:81-87.
47. Scheggi S, Masi F, Tagliamonte A, Gambarana C, Tolu P, De Montis MG (2000). Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress. Brain Res 853:290-298.
48. Serrano A, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2002). Effects of DA D1 and D2 antagonists on the sensitization to the motor effects of morphine in mice. Prog Neuro-psychopharmacol. Biol Psychiatry 26:1263-1271.
49. Shippenberg TS, Heidbreder CH, Lefevour A (1996). Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 299:33-39.
50. Spanagel R (1995). Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70:37-49.
51. Stefano GB, Salzet B, Rialas CM, Pope M, Kustka A, Neenan K, et al. (1997). Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 763:63-68.
52. Stefano GB, Cadet P, Fimiani C, Magazine HI (2001). Morphine stimulates iNOS expression via a rebound from inhibition in human macrophages: nitric oxide involvement. Int J Immunopathol Pharmacol 14:129-138.
53. Stewart J, Badiani A (1993). Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289-312.
54. Strasser A, McCarron RM, Ishii H, Stanimirovic D, Spatz M (1994). L-Arginine induces dopamine release from the striatum in vivo. NeuroReport 5:2298-3000.
55. Succu S, Mascia MS, Melis T, Melis MR, Deghenghi R, Argiolas A (2003). Activation of GABAA and opioid receptors reduce penile erection induced by hexarelin peptides. Pharmacol Biochem Behav 76:563-570.
56. Succu S, Mascia MS, Melis T, Sanna F, Boi A, Melis MR, Argiolas A (2006). Morphine reduces penile erection induced by the cannabinoid receptor antagonist SR 141617A in male rats: role of paraventricular glutamic acid and nitric oxide. Neurosci Lett 404:1-5.
57. Tayebi Meybodi K, Vakili Zarch A, Zarrindast MR, Djahanguiri B. (2005). Effects of ultra-low doses of morphine, naloxone and ethanol on morphine statedependent memory of passive avoidance in mice. Behav Pharmacol 16:139-145.
58. Taylor DA, Fleming WW (2001). Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11-18.
59. Toda N, Okamura T (2003). The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 55:271-324.
60. Watanabe C, Sakurada T, Okuda K, Sakurada C, Ando R, Sakurada S (2003). The role of spinal nitric oxide and glutamate in nociceptive behaviour evoked by high-dose intrathecal morphine in rats. Pain 106:269-283.
61. Weiss J, Thompson ML, Shuster L (1984). Effects of naloxone and naltrexone on drug-induced hypothermia in mice. Neuropharmacology 23:483-489.
62. Wells JL, Bartlett JL, Ananthan S, Bilsky EJ (2001). In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. J Pharmacol Exp Ther 297:597-605.
63. White NM (1996). Addictive drugs as reinforces: multiple partial actions on memory systems. Addiction 91:921-949.
64. Zarrindast MR, Zarghi A (1992). Morphine stimulates locomotor activity by an indirect dopaminergic mechanism: possible D-1 and D-2 receptor involvement. Gen Pharmacol 23:1221-1225.
65. Zarrindast MR, Rezayof A (2004). Morphine state-dependent learning: sensitization and interactions with dopamine receptors. Eur J Pharmacol 497:197-204.
66. Zarrindast MR, Nassiri-Rad S, Pazouki M (1999). Effects of dopaminergic agents on antinociception in formalin test. Gen Pharmacol 32:517-522.
67. Zarrindast MR, Dinkoub Z, Homayoun H, Bakhtiarian A, Khavandgar S (2002). Dopamine receptor mechanism(s) and morphine tolerance in mice. J Psychopharmacol 16:261-266.
68. Zarrindast MR, Gholami A, Sahraei H, Haeri-Rohani A (2003). Role of nitric oxide in the acquisition and expression of apomorphine- or morphine-induced locomotor sensitization. Eur J Pharmacol 482:205-213.
69. Zarrindast MR, Azami BN, Rostami P, Rezayof A (2006). Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference. Behav Brain Res 169:248-255.